0000920465-19-000025.txt : 20190131
0000920465-19-000025.hdr.sgml : 20190131
20190131184955
ACCESSION NUMBER: 0000920465-19-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190129
FILED AS OF DATE: 20190131
DATE AS OF CHANGE: 20190131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chawla Lakhmir S
CENTRAL INDEX KEY: 0001646626
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 19557259
MAIL ADDRESS:
STREET 1: 1960 KIRBY ROAD
CITY: MCLEAN
STATE: VA
ZIP: 22101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_154897857940267.xml
FORM 4
X0306
4
2019-01-29
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001646626
Chawla Lakhmir S
C/O LA JOLLA PHARMACEUTICAL COMPANY,
4550 TOWNE CENTRE COURT
SAN DIEGO
CA
92121
0
1
0
0
Chief Medical Officer
Common Stock
2019-01-29
4
P
0
800
5.55
A
3059
D
Common Stock
2019-01-29
4
P
0
1200
5.57
A
4259
D
Common Stock
2019-01-30
4
P
0
800
5.5699
A
5059
D
Common Stock
2019-01-30
4
P
0
200
5.57
A
5259
D
/s/ Ryan Murr, as attorney-in-fact for Lakhmir S. Chawla
2019-01-31